Tom de Swaan graduated from the University of Amsterdam with a master’s degree in economics. He joined De Nederlandsche Bank in 1972, and from 1986 to 1998 was a member of the governing board there. From January 1999 to May 2006 he was a member of the board of management and chief financial officer of ABN AMRO bank.
Mr. Tom de Swaan
Chairman of the Board
Mr. de Swaan is a non-executive member of the board of GlaxoSmithKline Plc and chairman of its Remuneration Committee. He is the chairman of the board of Zurich Insurance Group. He is vice-chairman of Royal Ahold, a global retail chain and chairman of the board of Van Lanschot Bankiers, a dutch private bank. He serves on the board of Royal DSM, a Netherlands based nutrition and specialty chemical company. He is a member of the Public Interest Committee of KPMG Europe LLP and a special advisor to ONDRA, a merchant bank in London. He was chairman of the Amsterdam Financial Center, and of the Banking Supervisory Committee of the European Monetary Institute. From 1991 to 1996 he was a member of the Basel Committee on Banking Supervision, and was its chairman from 1997 to 1998. Mr. de Swaan is director of a number of non-profit organizations. He is the chairman of the board of the Netherlands Cancer Institute and the Antoni van Leeuwenhoek hospital and treasurer of the Erasmus Prize Foundation and the International Liszt Piano Competition. Moreover, he chairs the advisory board of the Rotterdam School of Management. From 1986-2003 he served on the board of the Jewish Historical Museum Amsterdam, the last four years as chairman. He is the chairman of the Van Leer Jerusalem Institute since June 2006.
He was born on 4 March 1946; he is married and has two children and six grandchildren.